Navigation Links
Ridge Diagnostics, Inc. CEO to Speak at Neurotech Investing and Partnering Conference
Date:5/5/2011

SAN DIEGO, May 5, 2011 /PRNewswire/ -- Ridge Diagnostics, Inc., a neurodiagnostic company, announced that Lonna J. Williams, CEO will speak at the 6th Annual Neurotech Investing and Partnering Conference to be held in San Francisco, CA at the St. Regis Hotel on May 9th and 10th.  

Ms. Williams, a clinical diagnostics industry veteran, will participate on a panel entitled "Next Generation Psychiatry" lead by Dr. Manuel Lopez-Figueroa, Vice President, Bay City Capital. The panel will discuss the most promising next generation diagnostics, devices and treatments for neuropsychiatric disorders such as depression, schizophrenia, anxiety, addiction and others.

Ridge Diagnostics develops and sells blood tests which aid in the diagnosis and management of clinical depression or Major Depressive Disorder.  For the first time, a blood test provides clinicians and patients with objective, biologically based, diagnostic information to manage and treat this disorder.    Blood test results are intended to augment the current tools used for neuropsychiatric diagnosis and patient management.  Additional tests are in development for antidepressant efficacy monitoring and adolescent depression.

Ridge Diagnostics, Inc. Ridge Diagnostics is a neurodiagnostic company developing and marketing blood-based tests to diagnose and monitor neuropsychiatric disorders.  Ridge has commercialized the first-in-class, proprietary blood test for the diagnosis and treatment monitoring of Major Depressive Disorder (MDD).   The portfolio of neurodiagnostic blood tests are based on a proprietary Human Biomarker Library and Hyper-Mapping technology.  The testing services are provided by the Ridge owned CLIA laboratory. The company is located in San Diego, CA and Research Triangle Park, NC.   www.ridgedx.com

Neurotech Investing and Partnering Conference. The premier partnering and investing conference where investors, executives, entrepreneurs, scientists and others involved in the development of new treatments and diagnostics for the brain and nervous system come together to shape the future of their organization and the industry. Find out about next generation drugs, devices and diagnostics for Alzheimer's, addiction, anxiety, depression, Huntington's, ALS, pain, sensory disorders, obesity, stroke, schizophrenia, sleep disorders, epilepsy, multiple sclerosis, traumatic brain injury, spinal cord injury, Parkinson's and more.


'/>"/>
SOURCE Ridge Diagnostics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. HeartWare Reports Additional Data from Bridge-to-Transplant Clinical Trial and Continued Access Patients
2. Cempra Pharmaceuticals to Present at Two Upcoming Cambridge Healthtech Institute (CHI) Conferences
3. Breckenridge Pharmaceutical Enters Agreement with Oman Pharmaceutical Products Company LLC
4. BridgePoint Medical Names Industry Veteran as Chief Executive Officer
5. BridgePoint Medical Closes $9.1 Million Series C Financing
6. Sunridge Signs Distribution Agreement for Turkey
7. HeartWare Receives Third Patient Allotment From FDA - Authorizing 94 Additional Patients - Under Continued Access Protocol for Pivotal U.S. Bridge-to-Transplant Clinical Trial
8. Sunridge Moves Forward to Open Company Owned Clinics
9. Rockbridge Growth Equity Leads Acquisition of Connect America, a Leading Direct to Consumer Provider of Personal Emergency Response Systems (PERS)
10. HeartWare Files PMA Application for FDA Approval of the HeartWare® Ventricular Assist System for a Bridge-to-Transplant Indication
11. Caliper Life Sciences to Acquire Cambridge Research & Instrumentation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/12/2017)... -- Eli Lilly and Company (NYSE: LLY ) has ... pending patent litigation in the U.S. District Court for the ... Cialis ® (tadalafil) unit dose patent. This patent was ... of the agreement, Cialis exclusivity is now expected to end ... unit dose patent for Cialis is valid and infringed by ...
(Date:7/11/2017)... 11, 2017  Sysmex America, Inc., a leading ... equipment as well as middleware information systems technology, ... make quality assurance easier and more risk free ... known for the innovation that it delivers to ... quality assurance processes to a new level with ...
(Date:7/10/2017)... July 10, 2017 The Institute for In ... is the recipient of a VITROCELL® inhalation exposure system ... Science Consortium. The device, which is designed to replace ... human lung cells to airborne test materials in an ... the VITROCELL® system for testing combustible tobacco products, as ...
Breaking Medicine Technology:
(Date:7/27/2017)... ... July 27, 2017 , ... Georgia Urology , ... Dr. Brent Sharpe who is now serving urology patients in the Braselton and ... in Flowery Branch, and is open on Mondays, Tuesdays, Wednesdays, and Fridays. The Gainesville ...
(Date:7/27/2017)... (PRWEB) , ... July 27, 2017 , ... ... a new set of teeth in a single office visit from Dr. Alejandro ... comfortable treatment solutions to his East Texas patients, including Teeth-in-a-Day® dental implants ...
(Date:7/27/2017)... Santa Clara, CA (PRWEB) , ... July 27, ... ... technology, announces the addition of a secure cloud-based polysomnography (PSG) distributed scoring solution ... to support accelerated diagnostics and sleep care management. The speed and functionality of ...
(Date:7/27/2017)... ... ... Los Angeles leg of the US movie premier of the Man in the Camo Jacket ... Clive Davis Theater inside the Grammy Museum Located in downtown Los Angeles in the LA ... rock musician, Mike Peters (of The Alarm), his rise to fame, battle with cancer and ...
(Date:7/27/2017)... ... 2017 , ... Team Novo Nordisk, the world’s first all-diabetes professional cycling team, ... a stagiaire for the remainder of the 2017 season. One of our best development ... Tour of Utah. , “Every season we are excited to move an athlete from ...
Breaking Medicine News(10 mins):